Drawing for ASHION ANALYTICS

USPTO serial 86611243

ASHION ANALYTICS

Reviewed by CopyMark Law Group

Reg. 4957288Status 710
Filing date
Status date
Registration date
May 10, 2016
Examiner
CHISOLM, KEVON
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with ASHION ANALYTICS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Sana Hakim

Sana Hakim K&L Gates LLPP.O. Box 1135Chicago, IL 60690-1135UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Chemical test kits for genetic testing for laboratory or research use; Assays and reagents for use in genetic research; Genetic identity tests comprised of reagents; Diagnostic preparations for scientific or research use; Nucleic acid isolation and purification kit consisting primarily of reagents for scientific research purposes; Reagents for scientific or medical research use; Testing kits comprised of medical diagnostic reagents and assays that test for the presence of certain genetic propertiesSECTION 8 - CANCELLED—
005Diagnostic agents, preparations and substances for medical purposes; Medical diagnostic reagents for the analysis of genetic materialSECTION 8 - CANCELLED—
042Medical and scientific research in the field of genetic testing and diagnosis and treatment of medical conditions; Development and laboratory testing in the field of genetics and human disease; Scientific research consulting in the field of genetics, genomics, DNA sequencing, and bioinformatics; Consulting services in the field of pharmaceutical research and development and laboratory testing; Genetic research, development and testing services; Genomic research, development and testing services for scientific research purposes; DNA collection, testing and analysis services for scientific research purposes; Genetic testing for diagnostic purposes; Genomic testing for diagnostic purposes; Medical and scientific research, development and consulting in the field of oncology; Medical and scientific research in the field of genetics and genetic engineering; Medical and scientific research and consulting in the fields of genomics and generation sequencing; Medical and scientific research in the field of cancer treatment and diagnosis; Data collection for research purposes, namely, the collection, testing and research of patient molecular and/or genomic data; Scientific clinical studies, namely, conducting clinical trials for others; Retrieval and correlation of genomic data; Medical and scientific research relating to the design and development of cancer treatment therapies; Conducting clinical and pre-clinical trials; Diagnostic services in the field of molecular science, comparative genome analysis, DNA arrays and screening of nucleic acids; Research and development of identification and treatment methods for hereditary factors leading to disease; Identification of target molecules for cancer treatment; DNA-sequencing for scientific research purposes; Targeted pharmaceutical drug development services; Genotyping; Gene screening; Gene isolation and gene expression analysis for scientific research purposes; Gene mapping; Gene analysis and biomarker discovery for scientific research purposesSECTION 8 - CANCELLED—
044Medical testing for diagnostic or treatment purposes in the field of cancer research; Medical diagnostic testing, monitoring and reporting services; Medical evaluation services; Medical monitoring services; Medical diagnostic, prognostic and theranostic screening and testing; Collection and preservation of DNA for medical and research purposes; Consulting services in the field of healthcare and cancer diagnoses; Providing a website featuring health and healthcare information related to cancer research, testing and screening; Genetic testing for medical purposes; Providing information in the field of cancer prevention, screening, diagnosis and treatment for medical diagnostic and treatment purposes; Providing genetics assessments in the nature of genetic counseling; Molecular profiling services of patients for use in providing medical and related health care services to patientsSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 25, 2022C8..CANCELLED SEC. 8 (6-YR)—
Oct 8, 2021CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Oct 8, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 8, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 8, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 8, 2021COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Sep 15, 2021ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
May 10, 2021REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jan 25, 2021CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jan 25, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jan 25, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 25, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jan 25, 2021COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
May 10, 2016R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 2, 2016SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Apr 1, 2016CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Mar 11, 2016SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Mar 10, 2016AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Feb 5, 2016IUAFUSE AMENDMENT FILED—
Feb 5, 2016EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jan 26, 2016NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 1, 2015NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 1, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 11, 2015NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 23, 2015PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Oct 22, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 22, 2015DMCCDATA MODIFICATION COMPLETED—
Oct 22, 2015TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 22, 2015CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 22, 2015DMCCDATA MODIFICATION COMPLETED—
Oct 22, 2015ALIEASSIGNED TO LIE—
Oct 21, 2015TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 20, 2015CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 20, 2015TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 28, 2015GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 28, 2015GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 28, 2015CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 26, 2015DOCKASSIGNED TO EXAMINER—
May 7, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 30, 2015NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance